X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3726) 3726
female (3111) 3111
breast cancer (2391) 2391
oncology (2358) 2358
middle aged (2130) 2130
breast neoplasms - pathology (1800) 1800
cancer (1683) 1683
adult (1664) 1664
aged (1629) 1629
breast neoplasms - drug therapy (1269) 1269
prognosis (1153) 1153
carcinoma (1133) 1133
chemotherapy (859) 859
medicine & public health (819) 819
tumors (761) 761
surgery (722) 722
breast neoplasms - metabolism (714) 714
metastasis (681) 681
aged, 80 and over (662) 662
research (661) 661
care and treatment (656) 656
carcinoma, lobular - drug therapy (650) 650
neoplasm staging (648) 648
immunohistochemistry (644) 644
carcinoma, ductal, breast - drug therapy (627) 627
carcinoma, ductal, breast - pathology (617) 617
treatment outcome (609) 609
pathology (608) 608
expression (581) 581
carcinoma, lobular - pathology (573) 573
antineoplastic combined chemotherapy protocols - therapeutic use (558) 558
breast neoplasms - genetics (556) 556
analysis (549) 549
breast neoplasms - surgery (542) 542
male (538) 538
retrospective studies (514) 514
survival (513) 513
therapy (501) 501
health aspects (495) 495
animals (492) 492
follow-up studies (473) 473
gene expression (472) 472
risk factors (462) 462
chemotherapy, adjuvant (451) 451
breast neoplasms - mortality (430) 430
diagnosis (415) 415
genetic aspects (407) 407
neoadjuvant therapy (401) 401
hepatocellular-carcinoma (394) 394
biopsy (368) 368
women (356) 356
lymphatic metastasis (355) 355
survival rate (350) 350
development and progression (349) 349
receptor, erbb-2 - metabolism (344) 344
medicine (340) 340
carcinoma, ductal, breast - metabolism (331) 331
research article (330) 330
receptors, estrogen - metabolism (325) 325
neoadjuvant chemotherapy (317) 317
mastectomy (316) 316
breast neoplasms - therapy (314) 314
medical prognosis (313) 313
breast carcinoma (311) 311
neoplasm invasiveness (311) 311
disease-free survival (304) 304
proteins (298) 298
biomarkers, tumor - metabolism (297) 297
breast neoplasms - diagnosis (297) 297
cancer therapies (294) 294
patients (292) 292
cell biology (287) 287
tamoxifen (286) 286
estrogen (281) 281
hepatocellular carcinoma (278) 278
metastases (275) 275
gene expression regulation, neoplastic (273) 273
gastroenterology & hepatology (265) 265
antineoplastic agents - therapeutic use (261) 261
liver (261) 261
carcinoma, lobular - metabolism (260) 260
apoptosis (258) 258
mice (256) 256
skin and connective tissue diseases (252) 252
surgical oncology (251) 251
adjuvant treatment (250) 250
oncology, experimental (250) 250
cancer research (246) 246
receptors, progesterone - metabolism (246) 246
carcinoma, lobular - surgery (243) 243
mammography (243) 243
cancer patients (241) 241
carcinoma, ductal, breast - surgery (241) 241
mutation (241) 241
survival analysis (241) 241
carcinoma, lobular - secondary (240) 240
drug therapy (239) 239
cell line, tumor (237) 237
prospective studies (237) 237
young adult (237) 237
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4552) 4552
French (19) 19
Japanese (19) 19
Chinese (17) 17
German (15) 15
Spanish (9) 9
Hungarian (6) 6
Italian (3) 3
Norwegian (3) 3
Arabic (2) 2
Portuguese (2) 2
Romanian (2) 2
Czech (1) 1
Danish (1) 1
Dutch (1) 1
Polish (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International journal of radiation oncology, biology, physics, ISSN 0360-3016, 2014, Volume 88, Issue 3, pp. 553 - 564
...) and develop a guideline for defining adequate margins in the setting of breast conserving surgery and adjuvant radiation therapy... 
Radiology | Hematology, Oncology and Palliative Medicine | DOSE-ESCALATION | ADJUVANT BREAST | CONSERVATIVE TREATMENT | LOCAL RECURRENCE | ONCOLOGY | RANDOMIZED-TRIAL | FOLLOW-UP | RADICAL-MASTECTOMY | RADIOTHERAPY HYPOFRACTIONATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | LOCOREGIONAL RECURRENCE | LOBULAR CARCINOMA | Breast Neoplasms - surgery | Carcinoma, Lobular - pathology | Age Factors | Carcinoma in Situ - drug therapy | United States | Humans | Antineoplastic Agents - therapeutic use | Carcinoma in Situ - radiotherapy | Neoplasm, Residual | Societies, Medical | Carcinoma in Situ - surgery | Female | Radiotherapy, Adjuvant - standards | Retrospective Studies | Carcinoma, Lobular - surgery | Carcinoma in Situ - pathology | Chemotherapy, Adjuvant - standards | Mastectomy, Segmental - standards | Breast Neoplasms - drug therapy | Consensus | Neoplasms, Second Primary - prevention & control | Breast Neoplasms - radiotherapy | Carcinoma, Lobular - radiotherapy | Breast Neoplasms - pathology | Chemotherapy, Adjuvant - methods | Radiotherapy, Adjuvant - methods | Medical Oncology - standards | Carcinoma, Lobular - drug therapy | Neoplasm Staging | Radiation Oncology - standards | Lumpectomy | Sects | Medical colleges | Radiation | Breast cancer | Health aspects | Trade and professional associations | REVIEWS | SURGERY | PATIENTS | MAMMARY GLANDS | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | SAFETY MARGINS | RADIOTHERAPY
Journal Article
European journal of cancer (1990), ISSN 0959-8049, 2008, Volume 44, Issue 1, pp. 73 - 83
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2012, Volume 49, Issue 2, pp. 297 - 304
Journal Article
The lancet oncology, ISSN 1470-2045, 2012, Volume 13, Issue 9, pp. 887 - 896
Summary Background Little is known about the treatment of breast cancer during pregnancy. We aimed to determine whether treatment for breast cancer during... 
Hematology, Oncology and Palliative Medicine | ONCOLOGY | PROGNOSIS | PRETERM BIRTH | OUTCOMES | TAXANES | MODEL | ANTHRACYCLINES | CHEMOTHERAPY | CHILDREN | FEATURES | AGE | Breast Neoplasms - surgery | Multivariate Analysis | Carcinoma, Lobular - pathology | Infant, Newborn, Diseases - epidemiology | Birth Weight - drug effects | Carcinoma, Ductal - pathology | Humans | Middle Aged | Organ Preservation | Male | Infant, Newborn, Diseases - chemically induced | Carcinoma, Ductal - drug therapy | Pregnancy Outcome - epidemiology | Incidence | Young Adult | Apgar Score | Pregnancy Complications, Neoplastic - drug therapy | Adult | Female | Registries | Retrospective Studies | Infant, Newborn | Carcinoma, Lobular - secondary | Carcinoma, Lobular - surgery | Abnormalities, Drug-Induced - epidemiology | Europe | Lymphatic Metastasis | Carcinoma, Lobular - diagnosis | Breast Neoplasms - drug therapy | Pregnancy | Disease-Free Survival | Carcinoma, Ductal - secondary | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Carcinoma, Ductal - diagnosis | Breast Neoplasms - diagnosis | Carcinoma, Lobular - drug therapy | Delivery, Obstetric - statistics & numerical data | Neoplasm Staging | Cohort Studies | Care and treatment | Surgery, Plastic | Surgical clinics | Pregnant women | Oncology, Experimental | Breast cancer | Research | Drug therapy | Cancer
Journal Article
Journal Article
Journal Article
Breast cancer research and treatment, ISSN 0167-6806, 2012, Volume 136, Issue 1, pp. 35 - 43
Journal Article
Journal Article
The lancet oncology, ISSN 1470-2045, 2013, Volume 14, Issue 7, pp. 609 - 618
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2011, Volume 29, Issue 25, pp. 3366 - 3373
Journal Article